All the Active Ingredient Drugs
ENHERTU
Astra Zeneca
ENHERTU
Immunoglobulins. Trastuzumab deruxtecan 20 mg/ml. mAb linked to DXd, an exatecan deriv. and a
topoisomerase I inhibit.
Vial, 100 mg. Powd. for concentr. for sol. for inf.
Breast or Lung cancer: 5.4 mg/kg bw once every 21 days
Gastric cancer: 6.4 mg/kg once every 21 days.
Do not substitute with trastuzumab or ado-trastuzumab emtansine.
HER2-Posit. Metast. Breast Cancer ; HER2-Low Metast. Breast Cancer; Unresect. or Metast. HER2-Mutant Non-Small Cell Lung Cancer; Locally Adv. or Metast. Gastric Cancer. See Lit
C/I: Hypersens.